{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:12:26Z","timestamp":1778011946969,"version":"3.51.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pharmaceutical Research and Manufacturers of America"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Beginning in 2024, the Inflation Reduction Act (IRA) extended eligibility for full Medicare Part D low-income subsidies (LIS) to all partial-subsidy recipients but did not address the issue of low participation rates for both full and partial subsidies. This study examines how lack of LIS affects medication use among Medicare beneficiaries who meet program eligibility criteria but fail to enroll and whether alternative sources of prescription coverage mitigate the lack of subsidies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study used data from the 2019 Medicare Current Beneficiary Survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that LIS recipients averaged 49 prescriptions annually vs 25 for LIS-eligible non-enrollees and were 10% less likely to report cost-related nonadherence. Regression models controlling for differences between the two groups showed that LIS recipients filled 45% more prescriptions (P &amp;lt; 0.001) and that nonadherence was 1.4 times greater among those without subsidies (P = 0.014). Non-enrollees with unsubsidized Part D filled 39% fewer prescriptions than LIS recipients (P &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings provide a powerful policy endorsement of the value of Part D LIS for Medicare beneficiaries. Expanded LIS provided under provisions of the IRA together with a robust program designed to maximize LIS enrollment should lead to improved medication utilization within the eligible low-income beneficiary population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/haschl\/qxaf186","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:25:40Z","timestamp":1760617540000},"source":"Crossref","is-referenced-by-count":0,"title":["How lack of subsidized prescription drug coverage affects medication use by low-income Medicare beneficiaries"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3457-3010","authenticated-orcid":false,"given":"F Ellen","family":"Loh","sequence":"first","affiliation":[{"name":"Department of Social, Behavioral and Administrative Sciences, Touro College of Pharmacy , 2090 Adam Clayton Powell Jr. Blvd, Room 603E, New York, NY 10027, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-4078","authenticated-orcid":false,"given":"Bruce C","family":"Stuart","sequence":"additional","affiliation":[{"name":"Department of Practice, Sciences and Health Outcomes Research, University of Maryland School of Pharmacy , Baltimore, MD 21201, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J","family":"Hunt","sequence":"additional","affiliation":[{"name":"Department of Policy and Research, Pharmaceutical Research and Manufacturers of America (PhRMA) , Washington, DC 20024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiti","family":"Negari","sequence":"additional","affiliation":[{"name":"Department of Policy and Research, Pharmaceutical Research and Manufacturers of America (PhRMA) , Washington, DC 20024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0826-2737","authenticated-orcid":false,"given":"Jacquelyn","family":"McRae","sequence":"additional","affiliation":[{"name":"Department of Policy and Research, Pharmaceutical Research and Manufacturers of America (PhRMA) , Washington, DC 20024, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"key":"2026050515411601400_qxaf186-B1"},{"key":"2026050515411601400_qxaf186-B2","author":"Centers for Medicare and Medicaid Services"},{"issue":"3","key":"2026050515411601400_qxaf186-B3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.5034\/inquiryjrnl_49.03.04","article-title":"Eligibility and take-up of the Medicare Part D low-income subsidy","volume":"49","author":"Shoemaker","year":"2012","journal-title":"Inquiry"},{"key":"2026050515411601400_qxaf186-B4","author":"Popham"},{"issue":"3","key":"2026050515411601400_qxaf186-B5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.18553\/jmpc.2024.23174","article-title":"Medicare Part D low-income subsidies expanded in January 2024, but more needs to be done to ensure that eligible beneficiaries enroll","volume":"30","author":"Loh","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"2026050515411601400_qxaf186-B6","author":"Schoen"},{"key":"2026050515411601400_qxaf186-B7","author":"Medicaid and CHIP Payment and Access Commission"},{"issue":"4","key":"2026050515411601400_qxaf186-B8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/19371918.2018.1462285","article-title":"Awareness of the Medicare Part D low-income subsidy among older non-Hispanic Blacks and Hispanics","volume":"33","author":"Bakk","year":"2018","journal-title":"Soc Work in Public Health"},{"key":"2026050515411601400_qxaf186-B9","author":"Summer"},{"issue":"1","key":"2026050515411601400_qxaf186-B10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12913-022-07554-w","article-title":"A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health","volume":"22","author":"Guindon","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"2026050515411601400_qxaf186-B11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1475-9276-7-12","article-title":"What impact do prescription drug charges have on efficiency and equity: evidence from high-income countries","volume":"7","author":"Gemmill","year":"2008","journal-title":"Int J Equity Health"},{"key":"2026050515411601400_qxaf186-B12","volume-title":"Fact Sheet: Biden-Harris Administration Announces New Tools to Lower Prescription Drug Costs for Low-Income Seniors and People with Disabilities","author":"US Department of Health and Human Services","year":"12, 2023"},{"issue":"8","key":"2026050515411601400_qxaf186-B13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/jgs.12364","article-title":"The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D","volume":"61","author":"Wei","year":"2013","journal-title":"J Am Geriatrics Soc"},{"issue":"2","key":"2026050515411601400_qxaf186-B14","doi-asserted-by":"publisher","first-page":"CD000011","DOI":"10.1002\/14651858.CD000011.pub3","article-title":"Interventions for enhancing medication adherence","volume":"16","author":"Haynes","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"2026050515411601400_qxaf186-B15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/gerona\/glx256","article-title":"A systematic review and meta-analysis of the factors associated with nonadherence and discontinuation of statins among people age &gt;65 years","volume":"73","author":"Ofori-Asenso","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2026050515411601400_qxaf186-B16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2190\/4M3E-L0YF-W1TD-EKG0","article-title":"Effects of prescription drug user fees on drug and health service use on health status of vulnerable populations: a systematic review of the evidence","volume":"34","author":"Lexchin","year":"2004","journal-title":"Int J Health Serv"},{"issue":"1","key":"2026050515411601400_qxaf186-B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jama.298.1.61","article-title":"Prescription drug cost sharing associations with medication utilization and spending and health","volume":"298","author":"Goldman","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"2026050515411601400_qxaf186-B18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","article-title":"Patients at-risk for cost-related nonadherence: a review of the literature","volume":"22","author":"Briesacher","year":"2007","journal-title":"J Gen Intern Med"},{"key":"2026050515411601400_qxaf186-B19","author":"Schluterman"},{"key":"2026050515411601400_qxaf186-B20","author":"US Congress, Congressional Budget Office"}],"container-title":["Health Affairs Scholar"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/advance-article-pdf\/doi\/10.1093\/haschl\/qxaf186\/64811999\/qxaf186.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/4\/5\/qxaf186\/64811999\/qxaf186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/4\/5\/qxaf186\/64811999\/qxaf186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T19:41:26Z","timestamp":1778010086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article\/doi\/10.1093\/haschl\/qxaf186\/8293025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/haschl\/qxaf186","relation":{},"ISSN":["2976-5390"],"issn-type":[{"value":"2976-5390","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2025,10,18]]},"article-number":"qxaf186"}}